Cristy

Garza-Mayers

MD

PhD

Appointments

Seattle Children's

206.987.2158
Schedule Online

4800 Sand Point Way NE
Seattle, WA 98105

Biography 

Cristy Garza-Mayers, MD, PhD, (she/her) is an Adjunct Assistant Professor in the UW Department of Dermatology, and a board-certified pediatric dermatologist at Seattle Children's Hospital.  

Education & Training

Clinical Fellow, Pediatric Dermatology, University of Massachusetts Chan Medical School (2022)

Resident, Harvard Combined Dermatology Residency Training Program (2021)

Intern, Department of Pediatrics, Massachusetts General Hospital for Children (2018)

MD, Medicine, Harvard Medical School (2017)

PhD, Microbiology and Immunobiology, Harvard University (2014)

BA, Biology, Washington University in Saint Louis (2007)

HONORS 

Medical Scientist Training Program Trainee, NIH/Harvard Medical School (2009)

Poster Award, Massachusetts General Hospital Clinical Research Day (2016)

Poster Award, Society for Pediatric Dermatology Annual Meeting (2018)

William Weston Career Development Award, Society for Pediatric Dermatology (2023)

Eleanor Shore Faculty Development Award, Massachusetts General Hospital (2023)

Publications 

Selected Publications

Tissera KA, Hawryluk EB, Harris J, Garza-Mayers AC. Survey of Access to and Use of Narrowband UVB Phototherapy in Pediatric Vitiligo. Pediatr Dermatol. 2025 May-Jun;42(3):517-522. doi: 10.1111/pde.15937.

Tissera KA, Buros-Stein A, Delva C, Mayur O, Hawryluk EB, Harris J, Garza-Mayers AC. Investigation of Hearing Loss in Pediatric Vitiligo. Pediatr Dermatol. 2025 Mar 3. doi: 10.1111/pde.15921. 

Tissera KA, Buros-Stein A, Delva CA, Mayur O, Hawryluk EB, Harris J, Garza-Mayers AC. No Association of Pediatric Vitiligo With Visual Acuity Deficits. Pediatr Dermatol. 2025 Mar-Apr;42(2):318-321. doi: 10.1111/pde.15806. 

Tan AJ, Xia J, Glennon CM, Locascio JJ, Gabel CK, Nguyen ED, Chand S, Rrapi R, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D. Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study. J Am Acad Dermatol. 2024:S0190-9622(24)00997-6. doi: 10.1016/j.jaad.2024.06.058.

Xia J, Tan AJ, Nguyen ED, Chand S, Rrapi R, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St. John J, Nigwekar SU, Kroshinsky D. Prevalence and risk factors for development of recurrent calciphylaxis. J Am Acad Dermatol. 2024; S0190-9622(24)00380-3. doi: 10.1016/j.jaad.2024.02.019.